home / stock / aplt / aplt news

APLT News and Press, Applied Therapeutics Inc. From 07/06/20

Stock Information
Company Name: Applied Therapeutics Inc.
Stock Symbol: APLT
Market: NASDAQ
Website: appliedtherapeutics.com
Menu
APLT APLT Quote APLT Short APLT News APLT Articles APLT Message Board
Get APLT Alerts

News, Short Squeeze, Breakout and More Instantly...
APLT - Applied Therapeutics Takes Action Against Fraudulent "Short Report"

On July 1, 2020, a fraudulent “short report” was posted. The fraudulent report includes manipulated company graphs and figures, fraudulent misrepresentation of data, and factual misstatements. Applied Therapeutics will work with law enforcement and regulators to ensur...
APLT - Applied Therapeutics reports additional 40mg/kg data from adult galactosemia study

Applied Therapeutics (NASDAQ: APLT ) announces additional supportive biomarker efficacy and safety data for AT-007 in Galactosemia at 40 mg/kg. More news on: Applied Therapeutics, Inc., Healthcare stocks news, Read more ...

APLT - Applied Therapeutics Announces Start of AT-007 Pediatric Galactosemia Study; Releases Additional 40mg/kg Data from Adult Galactosemia Study

AT-007 pediatric Galactosemia study (ACTION-Galactosemia Kids) initiated Additional 40mg/kg adult cohort demonstrates incremental efficacy; data reinforces AT-007 favorable safety and efficacy profile NEW YORK, June 15, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasd...

APLT - Mixed shelf roundup - healthcare

The following healthcare companies have filed prospectuses for mixed shelf offerings: More news on: Genprex, Inc., Syros Pharmaceuticals, Inc., ChromaDex Corporation, Healthcare stocks news, , Read more ...

APLT - Applied Therapeutics to Present Data on AT-001 for the Treatment of Diabetic Cardiomyopathy at 2020 American Diabetes Association Virtual Scientific Sessions

NEW YORK, June 08, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced today that three abstract...

APLT - Applied Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference

NEW YORK, June 03, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced today that it will p...

APLT - Applied Therapeutics Announces Appointment of Dr. Chuck Silberstein, MD, MBA, CFA as Chief Financial Officer and Head of Business Development

NEW YORK, May 26, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced today the appointment...
APLT - Applied Therapeutics to Present at the UBS Global Healthcare Conference

NEW YORK, May 12, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced today that it will ...

APLT - Applied Therapeutics EPS beats by $0.16

Applied Therapeutics (NASDAQ: APLT ): Q1 GAAP EPS of -$0.59 beats by $0.16 . More news on: Applied Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

APLT - Applied Therapeutics Reports First Quarter 2020 Financial Results

NEW YORK, May 11, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today reported financial results for...
Previous 10 Next 10